Leading five pharmaceutical firms accounts for 60 percent in R&D investment

The combined turnover of the domestic pharmaceutical firms closing their fiscal year at December, including 37 KOSDAQ-listed pharmaceutical firms in 2001, marked an average growth rate of 9.8 percent, to 3.17 trillion won compared with the same period of the previous year, while R&D expenditures to turnover declined, according to a report released by the Korea Health Industry Development Instit...